Cureline, a US-based provider of human biospecimens (HBS) to the global biomedical research community, is establishing a clinical operations and research team in Lithuania. The team will be comprised of MS and PhD level research and medical professionals and is set to begin operations in early 2021. Cureline’s presence adds to the continually growing community of US companies in Lithuania’s Life Sciences ecosystem.
Operating out of its central biorepository and two laboratories in California, Cureline provides human tissue specimens for therapeutic and diagnostic R&D around the globe.
Its partners include world leading pharmaceutical companies in the US, Europe, Korea and Japan, major universities and research institutes including Stanford, Harvard, and University of California San Francisco.